50PExtracellular Vesicle-Internalizing Receptors (EVIRs) for Dendritic Cell-Based Tumor Vaccines

Annals of Oncology - United Kingdom
doi 10.1093/annonc/mdx711.031
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Dendritic-Tumor Fusion Cell-Based Cancer Vaccines

International Journal of Molecular Sciences
Organic ChemistryMolecular BiologyTheoretical ChemistryInorganic ChemistryComputer Science ApplicationsSpectroscopyMedicineCatalysisPhysical
2016English

Tumor-Mediated Suppression of Dendritic Cell Vaccines

2004English

Immunotherapy of Cancer With Dendritic Cell-Based Vaccines

Gene Therapy
Molecular MedicineGeneticsMolecular Biology
1998English

Systemic Administration of Interleukin 2 Enhances the Therapeutic Efficacy of Dendritic Cell-Based Tumor Vaccines

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
1999English

Maturation and Trafficking of Monocyte-Derived Dendritic Cells in Monkeys: Implications for Dendritic Cell-Based Vaccines

Journal of Immunology
AllergyImmunology
2000English

Allogeneic Tumor Cell Vaccines

Human Vaccines and Immunotherapeutics
MedicineAllergyImmunologyPharmacology
2013English

Clinical Applications of Dendritic Cell Cancer Vaccines

Oncologist
Cancer ResearchMedicineOncology
1999English

Exploiting a New Strategy to Induce Immunogenic Cell Death to Improve Dendritic Cell-Based Vaccines for Lymphoma Immunotherapy

OncoImmunology
OncologyAllergyImmunology
2017English

Tumor-Altered Dendritic Cell Function: Implications for Anti-Tumor Immunity

Frontiers in Immunology
AllergyImmunology
2013English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy